IP Verse

Institut National De La Sant Et De La Recherche Mdicale Inserm competitive analysis

Loading summary...

Latest patents of Institut National De La Sant Et De La Recherche Mdicale Inserm opposed by its competitors

Explore Institut National De La Sant Et De La Recherche Mdicale Inserm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3911354
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin Gene4
EP3920970
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
EP3444271
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based Modulokines2
EP3256573
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange Chromatography1
EP2900820
Nov 18, 2020Methods For Producing A Population Of Pancreatic Beta-Cells1
EP2909232
Mar 11, 2020Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)1
EP3030575
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based Modulokines1

Latest publications and patents of Institut National De La Sant Et De La Recherche Mdicale Inserm New

Explore the latest publications and patents granted to Institut National De La Sant Et De La Recherche Mdicale Inserm, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Institut National De La Sant Et De La Recherche Mdicale Inserm

EP3911354
Apr 3, 2024Aav-Mediated Gene Therapy Restoring The Otoferlin GeneGranted And Under Opposition
EP3920970
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse EventsGranted And Under Opposition
EP3444271
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based ModulokinesGranted And Under Opposition
EP3256573
Dec 9, 2020Recombinant Adeno-Associated Virus Particle Purification With Multiple-Step Anion Exchange ChromatographyGranted And Under Opposition
EP2900820
Nov 18, 2020Methods For Producing A Population Of Pancreatic Beta-CellsPatent Maintained As Amended
EP2909232
Mar 11, 2020Methods And Pharmaceutical Compositions For The Treatment Of Age-Related Macular Degeneration (Amd)Revoked
EP3030575
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based ModulokinesOpposition Rejected
EP2790718
Feb 7, 2018Antagonist Of The Fibroblast Growth Factor Receptor 3 (Fgfr3) For Use In The Treatment Or The Prevention Of Skeletal Disorders Linked With Abnormal Activation Of Fgfr3No Opposition Filed Within Time Limit
EP3054962
Jan 31, 2018Puma Protein Expression Vector And Use Thereof In Gene TherapyNo Opposition Filed Within Time Limit
EP2895189
Jan 10, 2018Peptide Antagonists Of The Vasopressin-2 ReceptorNo Opposition Filed Within Time Limit

Latest PTAB cases involving Institut National De La Sant Et De La Recherche Mdicale Inserm

Discover the latest PTAB cases involving Institut National De La Sant Et De La Recherche Mdicale Inserm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Institut National De La Sant Et De La Recherche Mdicale Inserm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE INSERM - 11 - -
DIAMYD MEDICAL1 - - -
D YOUNG29 - - -
HGF74 - - -